Teva Pharma B.V.
π³π±Netherlands
Prospective Observational Study in Patients With Metastatic Breast Cancer Treated With Anthracyclines
Completed
- Conditions
- Metastatic Breast Cancer
- First Posted Date
- 2012-03-16
- Last Posted Date
- 2016-04-25
- Lead Sponsor
- Teva Pharma
- Target Recruit Count
- 60
- Registration Number
- NCT01555944
- Locations
- π§πͺ
AZ Damiaan, Oostende, Belgium
π§πͺZNA Middelheim, Antwerp, Belgium
π§πͺCliniques du Sud Lux - St Joseph, Arlon, Belgium
Β© Copyright 2025. All Rights Reserved by MedPath